...
Plan | Actual |
Describe Intervention Chosen intervention: Provide Statin Education to providers during regularly scheduled provider meeting – CDPHP to come onsite. Awaiting presentation. Plan for intervention: CDPHP to come onsite for 1-hour educational session during provider meeting on a TBD date. | Chosen Intervention: Date when implemented: Updates: |
Reach (#/% patients – or providers, for provider-facing interventions – who participated in intervention) | |
Reach of implementers/providers? Planned: 18 providers | Reach of implementers/providers? Actual: |
Reach of patients? Planned: N/A | Reach of patients? Actual: |
Efficacy (Impact of intervention on important outcomes) | |
How will you measure that your intervention is working? Pre/post-test or provider feedback | Were you able to accurately measure how your intervention was working? |
What outcomes do you expect? Improved test score from pre to post-test. | What outcomes have you seen? |
How will you ensure your intervention will be effective for your target population? CMO to review presentation for appropriateness. | Did your intervention reach the target population? |
What unintended consequences or outcomes might there be? Provider frustration/pushback at pre/post-tests. | What unintended outcomes did you experience? |
Adoption (#/% and representativeness of staff and sites who implemented the intervention) How did clinicians respond to interventions to intensify medication more rapidly/address therapeutic inertia? | |
Who will deliver the intervention (actually do the work)? Include staff and sites, if applicable. CDPHP to present at Schenectady site in conjunction with CMO/QM. | Who delivered the intervention? Did they have the skills and time needed to complete the intervention? |
How will you know if clinicians/care teams/sites used the intervention? Meeting attendance. | What proportion of the planned staff/sites implemented the intervention? Were there any differences between care teams/sites who adopted the intervention best vs. others who did not (e.g., differences in staff types, capacity, etc.)? |
Implementation Fidelity (How closely the staff/sites followed the intervention design, delivered it as intended – also called fidelity to the intervention) | |
How will you know what adaptations or modifications were made during the intervention? Provider engagement with presenters/CMO. | How did you track modifications during the intervention? |
What might be some of the possible obstacles to consistent implementation? Staff call outs/provider schedules. | What were the barriers to consistent intervention implementation? |
What costs and resources (including time and burden, not just money) need to be considered? Provider Time: 1 hour block to provider schedules | What costs and resources (including time and burden, not just money) need to be considered? |
How closely did the staff/sites follow the intervention design and deliver as intended? Check all that apply:
Modifications made and other notes: | |
Maintenance (Extent to which intervention is part of routine practices and protocols) | |
What reinforcements will you put in place to sustain the intervention, if effective?
Explain: If proven effective, we may offer regular trainings by CDPHP or other plans. Potentially will develop a protocol. | What reinforcements did you put into place to sustain the intervention?
Explain: |
How will you spread your intervention and lessons learned? Touchbase with providers at 1 mo month post training to get provider feedback on what’s working/what’s not, etc. | How will you spread your intervention and lessons learned? |
What are likely modifications or adaptations that will need to be made to sustain the intervention over time (e.g., lower cost, different staff, reduced intensity, different settings)? |
Intervention #2 Plan | Intervention #2 Actual |
Describe Intervention Chosen intervention: Patient outreach (2) weekly, utilizing Relevant report. Focus on patients with LDL > 190 who are not on statin. Plan for intervention: Case Manager to outreach via report weekly | Chosen Intervention: Date when implemented: Updates: |
Reach (#/% patients – or providers, for provider-facing interventions – who participated in intervention) | |
Reach of implementers/providers? Planned: N/A | Reach of implementers/providers? Actual: |
Reach of patients? Planned: 40 patients | Reach of patients? Actual: |
Efficacy (Impact of intervention on important outcomes) | |
How will you measure that your intervention is working? Via monthly data pull of patients with LDL greater than 190 who are on prescription. | Were you able to accurately measure how your intervention was working? |
What outcomes do you expect? We would expect that number of patients who have LDL greater than 190 who are actively on prescription would increase. | What outcomes have you seen? |
How will you ensure your intervention will be effective for your target population? This will tie back to reports and monthly data. | Did your intervention reach the target population? |
What unintended consequences or outcomes might there be? Patient refusal to take statin, refusal to engage in care, inability to contact patient, inability to afford medication. | What unintended outcomes did you experience? |
Adoption (#/% and representativeness of staff and sites who implemented the intervention) How did clinicians respond to interventions to intensify medication more rapidly/address therapeutic inertia? | |
Who will deliver the intervention (actually do the work)? Include staff and sites, if applicable. Case Managers in conjunction with the Manager of Case Management. | Who delivered the intervention? Did they have the skills and time needed to complete the intervention? |
How will you know if clinicians/care teams/sites used the intervention? Supervision of spreadsheet by the Manager of Case Management. | What proportion of the planned staff/sites implemented the intervention? Were there any differences between care teams/sites who adopted the intervention best vs. others who did not (e.g., differences in staff types, capacity, etc.)? |
Implementation Fidelity (How closely the staff/sites followed the intervention design, delivered it as intended – also called fidelity to the intervention) | |
How will you know what adaptations or modifications were made during the intervention? Documentation via spreadsheet. | How did you track modifications during the intervention? |
What might be some of the possible obstacles to consistent implementation? Decreased staffing in Case Management Department, competing priorities. | What were the barriers to consistent intervention implementation? |
What costs and resources (including time and burden, not just money) need to be considered? Time with being short-staffed 2 Case Manager’s. | What costs and resources (including time and burden, not just money) need to be considered? |
How closely did the staff/sites follow the intervention design and deliver as intended? Check all that apply:
Modifications made and other notes: | |
Maintenance (Extent to which intervention is part of routine practices and protocols) | |
What reinforcements will you put in place to sustain the intervention, if effective?
Explain: Pulling monthly data, reporting out to CM staff on updates | What reinforcements did you put into place to sustain the intervention?
Explain: |
How will you spread your intervention and lessons learned? Discuss at Interdepartmental/Quality Meetings, Statin (Diabetics) Quality Dashboard inclusion. | How will you spread your intervention and lessons learned? |
What are likely modifications or adaptations that will need to be made to sustain the intervention over time (e.g., lower cost, different staff, reduced intensity, different settings)? |
...